Lauramine oxide

CAS No. 1643-20-5

Lauramine oxide( Refan | Dimethylaurylamine oxide | LDAO | Lauryldimethylamine oxide )

Catalog No. M27347 CAS No. 1643-20-5

Lauramine oxide is effective against common bacteria such as E. coli and S. aureus, however it is non-denaturing and may be used to solubilize proteins.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
500MG 26 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Lauramine oxide
  • Note
    Research use only, not for human use.
  • Brief Description
    Lauramine oxide is effective against common bacteria such as E. coli and S. aureus, however it is non-denaturing and may be used to solubilize proteins.
  • Description
    Lauramine oxide is effective against common bacteria such as E. coli and S. aureus, however it is non-denaturing and may be used to solubilize proteins.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    Refan | Dimethylaurylamine oxide | LDAO | Lauryldimethylamine oxide
  • Pathway
    GPCR/G Protein
  • Target
    Antibacterial
  • Recptor
    AChR|BChE|Calcium Channel|cAMP|Parasite|DPPH
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1643-20-5
  • Formula Weight
    229.408
  • Molecular Formula
    C14H31NO
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 100 mg/mL (435.92 mM)
  • SMILES
    CCCCCCCCCCCC[N+](C)(C)[O-]
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Nasrullah AA, et al. Antiplasmodial alkaloids from the bark of Cryptocarya nigra (Lauraceae). Molecules. 2013 Jul 8;18(7):8009-17.
molnova catalog
related products
  • 1,3-DIMETHYL-2-OXO-2...

    1,3-DIMETHYL-2-OXO-2,3-DIHYDRO-1H-BENZIMIDAZOLE-5-CARBALDEHYDE

  • Ceftobiprole medocar...

    Ceftobiprole medocaril is the parenteral prodrug of Ceftobiprole. Ceftobiprole is a broad-spectrum cephalosporin with activity against Methicillin-resistant staphylococcus aureus (MRSA).

  • DS-2969b

    DS-2969b (DS 11960558) is a novel orally active GyrB inhibitor, inhibits the supercoiling activity of C. difficile DNA gyrase with IC50 of 20 ng/mL.